The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABCAM PLC | ADS | 000380204 | 2,058 | 142,350 | SH | SOLE | 142,350 | 0 | 0 | ||
ADVISORSHARES TR | PURE US CANNABIS | 00768Y453 | 2,216 | 214,100 | SH | SOLE | 214,100 | 0 | 0 | ||
AIRSCULPT TECHNOLOGIES INC | COM | 009496100 | 9,695 | 1,634,941 | SH | SOLE | 1,634,941 | 0 | 0 | ||
ALCON AG | ORD SHS | H01301128 | 21,884 | 313,115 | SH | SOLE | 313,115 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 24,882 | 376,600 | SH | SOLE | 376,600 | 0 | 0 | ||
AVANTI ACQUISITION CORP | UNIT 99/99/9999 | G0682V117 | 10,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BELLRING BRANDS INC | COMMON STOCK | 07831C103 | 4,657 | 187,122 | SH | SOLE | 187,122 | 0 | 0 | ||
BIO-TECHNE CORP | COM | 09073M104 | 501 | 1,444 | SH | SOLE | 1,444 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 17,220 | 207,800 | SH | SOLE | 207,800 | 0 | 0 | ||
CAESARS ENTERTAINMENT INC NE | COM | 12769G100 | 15,770 | 411,753 | SH | SOLE | 411,753 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 26,931 | 318,300 | SH | SOLE | 318,300 | 0 | 0 | ||
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 31,935 | 68,159 | SH | SOLE | 68,159 | 0 | 0 | ||
CLARIVATE PLC | ORD SHS | G21810109 | 22,749 | 1,641,319 | SH | SOLE | 1,641,319 | 0 | 0 | ||
DERMTECH INC | COM | 24984K105 | 1,943 | 350,800 | SH | SOLE | 350,800 | 0 | 0 | ||
DOCEBO INC | COM | 25609L105 | 4,309 | 150,300 | SH | SOLE | 150,300 | 0 | 0 | ||
FLAME ACQUISITION CORP | COM CL A | 33850F108 | 4,895 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
GODADDY INC | CL A | 380237107 | 31,020 | 445,953 | SH | SOLE | 445,953 | 0 | 0 | ||
HUMANA INC | COM | 444859102 | 16,382 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,251 | 278,000 | SH | SOLE | 278,000 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 8,936 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 12,940 | 119,779 | SH | SOLE | 119,779 | 0 | 0 | ||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 11,023 | 956,014 | SH | SOLE | 956,014 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 3,491 | 55,890 | SH | SOLE | 55,890 | 0 | 0 | ||
MORGAN STANLEY | COM NEW | 617446448 | 26,029 | 342,214 | SH | SOLE | 342,214 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 777 | 289,000 | SH | SOLE | 289,000 | 0 | 0 | ||
NEXIMMUNE INC | COM | 65344D109 | 644 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
POST HLDGS INC | COM | 737446104 | 8,260 | 100,298 | SH | SOLE | 100,298 | 0 | 0 | ||
POST HOLDINGS PARTNERING COR | UNIT 99/99/9999 | 737465203 | 12,213 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
PRIVIA HEALTH GROUP INC | COM | 74276R102 | 1,293 | 44,400 | SH | SOLE | 44,400 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 2,342 | 144,684 | SH | SOLE | 144,684 | 0 | 0 | ||
R1 RCM INC | COM | 77634L105 | 3,899 | 186,000 | SH | SOLE | 186,000 | 0 | 0 | ||
RXSIGHT INC | COM | 78349D107 | 4,667 | 331,432 | SH | SOLE | 331,432 | 0 | 0 | ||
SURROZEN INC | CL A | 86889P109 | 2,100 | 700,001 | SH | SOLE | 700,001 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 89 | 466,666 | SH | SOLE | 466,666 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 11,280 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
THE BEAUTY HEALTH COMPANY | COM CL A | 88331L108 | 14,078 | 1,094,710 | SH | SOLE | 1,094,710 | 0 | 0 | ||
UBER TECHNOLOGIES INC | COM | 90353T100 | 20,323 | 993,309 | SH | SOLE | 993,309 | 0 | 0 | ||
VERISIGN INC | COM | 92343E102 | 15,688 | 93,753 | SH | SOLE | 93,753 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 20,591 | 73,072 | SH | SOLE | 73,072 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 767 | 66,300 | SH | SOLE | 66,300 | 0 | 0 | ||
WILLIAMS ROWLAND ACQUISITION | *W EXP 12/11/202 | 96951B110 | 40 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
WILLIAMS ROWLAND ACQUISITION | COM | 96951B102 | 9,500 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 2,355 | 77,400 | SH | SOLE | 77,400 | 0 | 0 |